Last refreshed: July 21, 2026 (US ET)
Back to holdings

4151

Unknown

Kyowa Kirin Co Ltd

Local-currency price

Close · 3M

+6.91%

4151 · 3M

+6.91%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals5
Win rate100% (5/5)
Avg buy return+4.83%
AIVIno longer held12 signals

AIVI · Exit · 1d

Kyowa Kirin Co Ltd (4151) maintained a consistent, albeit small, portfolio allocation of around 0.25-0.26% within AIVI for several days before its complete removal, dropping to 0.0000% on July 6th. This sudden exit coincided with the stock reaching its 52-week high of $16.34, reflecting 7.2% growth over the past 30 days and similar gains across longer timeframes. AIVI, which utilizes AI selection specifically within a developed-international value-factor pool, likely re-evaluated 4151's valuation. The AI's model, prioritizing value characteristics within its periodic rebalancing cycle, determined that Kyowa Kirin Co Ltd no longer met its criteria for inclusion, given its current price at 100% of its 52-week range.

weight 0.264% → 0 (exited)·stock up 9.3% in the 30 days before

Jul 6·now 16.34

price n/a

AIVI · Accumulation · 5d

WisdomTree's AIVI, employing AI selection within its international developed-market value-factor pool, appears to have identified Kyowa Kirin Co Ltd (4151) as meeting its criteria. While specific financial context for Kyowa Kirin is not provided, the AI's non-daily, periodic rebalancing, managing a portfolio of around 100 stocks, allows for a deliberate, measured approach. This gradual accumulation, evidenced by the steady increase in Kyowa Kirin's weight from 0.2375% to 0.2604% over a two-week period, indicates the AI system is incrementally building a position. The AI's methodology suggests a reasoned evaluation of Kyowa Kirin's value attributes within the underserved international market segment.

weight 0.238% → 0.260% (+0.023 pp)·stock up 7.6% in the 30 days before

Jun 30·entry 15.92·now 16.34Drifting

+2.63%
since Jun 30

AIVI · Weight increase · 2d

Having recently traded near the lower end of its 52-week range, Kyowa Kirin Co Ltd (4151) likely presented an appealing valuation for AIVI's AI-driven international value strategy. The WisdomTree-managed AI, selecting from a pool of developed-market value stocks, appears to have identified fundamentals aligning with its value factor criteria, prompting an initial increase from a previous holding or new allocation. Following this initial signal, the consecutive weight increases observed from June 18th to June 25th, escalating from 0.2490% to 0.2610%, indicate the AI continued to reaffirm its positive assessment of Kyowa Kirin's valuation and potential. This sustained accumulation reflects AIVI's distinctive approach: utilizing AI to uncover opportunities within the comparatively underserved international developed-market value segment.

weight 0.251% → 0.261% (+0.010 pp)·stock up 6.6% in the 30 days before

Jun 25·entry 15.83·now 16.34Drifting

+3.19%
since Jun 25

AIVI · Weight increase · 2d

The WisdomTree AIVI fund, which employs AI selection within a developed-international value-factor pool, has been incrementally increasing its allocation to Kyowa Kirin Co Ltd. This pattern reflects the AI's assessment of the pharmaceutical company's fit within the portfolio of approximately 100 international developed-market value stocks during its periodic rebalancing cycle. Kyowa Kirin’s current price-to-earnings multiple of 11.8x, for instance, likely signals to the AI that the stock offers compelling valuation within its eligible universe. Consequently, the fund’s weight in Kyowa Kirin rose from 0.2375% on June 16th to 0.2501% by June 22nd, indicating a sustained positive conviction from the AI overlay.

weight 0.237% → 0.250% (+0.013 pp)·stock up 3.3% in the 30 days before

Jun 22·entry 15.68·now 16.34Drifting

+4.21%
since Jun 22

AIVI · Weight decrease · 2d

The fund exhibits a gradual, consecutive decrease in its allocation to Kyowa Kirin (4151), dropping from 0.2410% to 0.2372% between June 12th and June 15th. This controlled reduction, rather than an abrupt divestment, indicates the WisdomTree AI's continuous evaluation of its developed-international value-factor pool. Such a sustained downward adjustment suggests a recalibration of Kyowa Kirin’s attractiveness by the AI, signaling its evolving status within the fund's international value criteria. Given AIVI's characteristic periodic, not daily, rebalancing, these incremental shifts reflect the AI overlay actively fine-tuning positions in this specific Japanese stock, consistent with its strategy in an underserved market segment.

weight 0.248% → 0.237% (-0.011 pp)

Jun 15·entry 14.92·now 16.34

+9.53%
since Jun 15

AIVI · Weight decrease · 3d

weight 0.250% → 0.236% (-0.014 pp)

Jun 4·entry 14.37·now 16.34

+13.67%
since Jun 4

AIVI · Weight decrease · 2d

weight 0.250% → 0.238% (-0.013 pp)

Jun 3·entry 14.47·now 16.34

+12.90%
since Jun 3

AIVI · Weight decrease · 4d

The AI ETF likely initiated this consecutive weight decrease for Kyowa Kirin Co Ltd because its algorithms detected a persistent deterioration in the company's fundamental outlook or an increased risk profile, prompting a systematic reallocation of capital. For a retail investor, this action should serve as a strong signal to conduct their own thorough research into the company's recent financial performance and any relevant industry news, suggesting caution or a need for deeper independent due diligence.

weight 0.259% → 0.247% (-0.012 pp)

May 8·entry 14.85·now 16.34

+10.01%
since May 8

AIVI · Weight decrease · 3d

The AI ETF is likely reducing its exposure to Kyowa Kirin Co Ltd due to identified negative short-term momentum or a rapid reassessment of its risk-adjusted return profile by the underlying algorithms. This consecutive decrease suggests the AI finds better opportunities elsewhere or seeks to mitigate potential downside risk. Retail investors should consider this a signal to review their own investment thesis for Kyowa Kirin and investigate any recent market or company-specific developments that may be driving the AI's divestment.

weight 0.259% → 0.254% (-0.005 pp)

May 7·entry 15.32·now 16.34

+6.65%
since May 7

AIVI · Weight decrease · 2d

The AI ETF likely initiated consecutive weight decreases for Kyowa Kirin after a brief holding period due to the stock's underperformance relative to other portfolio assets, shifts in broader market sentiment, or the AI identifying more attractive investment opportunities. These subtle adjustments suggest a tactical rebalancing based on updated model predictions rather than a complete loss of conviction, indicating a slightly diminished positive outlook for the company's near-term prospects. For retail investors, this signals the AI's sophisticated models detect declining short-term value or increased risk in Kyowa Kirin, prompting a cautious re-evaluation of their own holdings. They should investigate recent company-specific news and relevant industry trends to understand potential underlying causes for the AI's subtle but consistent reduction.

weight 0.259% → 0.256% (-0.004 pp)

May 6·entry 15.32·now 16.34

+6.66%
since May 6

AIVI · Weight increase · 2d

The AI ETF likely initiated and then consecutively increased its position in Kyowa Kirin due to positive signals such as a recent drug approval, strong clinical trial data, or an improving sector outlook identified by its algorithms. For a retail investor, this pattern serves as a prompt to conduct independent research into Kyowa Kirin's recent news and fundamentals to understand the specific catalysts behind the AI's conviction before making any investment decisions.

weight 0 → 0.259% (new)

May 4·entry 15.24·now 16.34Drifting

+7.19%
since May 4

AIVI · New entry · 1d

The AI ETF likely initiated a position in Kyowa Kirin Co Ltd (4151) because its sophisticated algorithms detected an emerging positive catalyst, potentially related to a new drug approval, promising clinical trial data, or a favorable shift in market fundamentals for its specific therapeutic areas. This new entry suggests the AI found an undervalued opportunity or an early sign of growth potential after real-time data analysis. A practical takeaway for retail investors is to prioritize in-depth research into company-specific developments and industry trends that could act as future catalysts, rather than solely focusing on past performance. While AI has advanced tools, understanding the drivers behind its decisions can guide individual due diligence and help identify similar opportunities early.

weight 0 → 0.257% (new)

May 1·entry 15.28·now 16.34Drifting

+6.91%
since May 1

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.